Medical devices, healthcare technology and the business of care
510(k) clearance · K263352

TeKBrace Knotless Anchor

TheraMicro · Decision date Oct 21, 2026

MEDTECHLEDGER EXPLANATIONK263352

What did the FDA decide?

The FDA recorded a substantial equivalence determination, decision code SESE, on October 21, 2026 for TeKBrace Knotless Anchor, submitted by TheraMicro of Cordova, Tennessee under premarket notification K263352. The device falls in the orthopedic specialty under product code MBI. The available record identifies the submission as a section 510(k) premarket notification; it does not describe the device's components, materials, sizes or design features beyond the product name.

The decision letter states that the device is substantially equivalent, for the indications for use stated in the enclosure, to legally marketed predicate devices. Substantial equivalence under section 510(k) is a clearance to market, not premarket approval. The enclosure carrying the indications for use is not included in the retrieved excerpt, and the record shows no supplement type or reason, so no cleared labeling, predicate identity or clinical data can be reported here.

The source data do not state the predicate device or devices, the indications for use, or any conditions of clearance. Readers should treat the clearance date and decision code as the confirmed facts and consult the full FDA document for labeling scope.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Oct 21, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263352
Regulatory pathway
510(k) premarket notification
Applicant
TheraMicro
Product code
MBI
Decision code
SESE
Decision date
Oct 21, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Fastener, Fixation, Nondegradable, Soft Tissue.

Applicant
TheraMicro
Product code
MBI
FDA device class
2

FDA decision timeline

  1. K263352 received

    Application receipt date recorded by FDA.

  2. K263352 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MBI

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

TheraMicro

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Cordova, TN

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records